Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Karagas Margaret) "

Sökning: WFRF:(Karagas Margaret)

  • Resultat 11-16 av 16
  • Föregående 1[2]
Sortera/gruppera träfflistan
  • Figueroa, Jonine D., et al. (författare)
  • Genome-wide association study identifies multiple loci associated with bladder cancer risk
  • 2014
  • Ingår i: Human Molecular Genetics. - Oxford University Press. - 0964-6906 .- 1460-2083. ; 23:5, s. 1387-1398
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>andidate gene and genome-wide association studies (GWAS) have identified 11 independent susceptibility loci associated with bladder cancer risk. To discover additional risk variants, we conducted a new GWAS of 2422 bladder cancer cases and 5751 controls, followed by a meta-analysis with two independently published bladder cancer GWAS, resulting in a combined analysis of 6911 cases and 11 814 controls of European descent. TaqMan genotyping of 13 promising single nucleotide polymorphisms with <em>P</em> &lt; 1 × 10<sup>−5</sup> was pursued in a follow-up set of 801 cases and 1307 controls. Two new loci achieved genome-wide statistical significance: rs10936599 on 3q26.2 (<em>P</em> = 4.53 × 10<sup>−9</sup>) and rs907611 on 11p15.5 (<em>P</em> = 4.11 × 10<sup>−8</sup>). Two notable loci were also identified that approached genome-wide statistical significance: rs6104690 on 20p12.2 (<em>P</em> = 7.13 × 10<sup>−7</sup>) and rs4510656 on 6p22.3 (<em>P</em> = 6.98 × 10<sup>−7</sup>); these require further studies for confirmation. In conclusion, our study has identified new susceptibility alleles for bladder cancer risk that require fine-mapping and laboratory investigation, which could further understanding into the biological underpinnings of bladder carcinogenesis.</p>
  • Figueroa, Jonine D., et al. (författare)
  • Genome-wide interaction study of smoking and bladder cancer risk
  • 2014
  • Ingår i: Carcinogenesis. - Oxford University Press. - 0143-3334 .- 1460-2180. ; 35:8, s. 1737-1744
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Bladder cancer is a complex disease with known environmental and genetic risk factors. We performed a genome-wide interaction study (GWAS) of smoking and bladder cancer risk based on primary scan data from 3002 cases and 4411 controls from the National Cancer Institute Bladder Cancer GWAS. Alternative methods were used to evaluate both additive and multiplicative interactions between individual single nucleotide polymorphisms (SNPs) and smoking exposure. SNPs with interaction P values &lt; 5 x 10(-5) were evaluated further in an independent dataset of 2422 bladder cancer cases and 5751 controls. We identified 10 SNPs that showed association in a consistent manner with the initial dataset and in the combined dataset, providing evidence of interaction with tobacco use. Further, two of these novel SNPs showed strong evidence of association with bladder cancer in tobacco use subgroups that approached genome-wide significance. Specifically, rs1711973 (FOXF2) on 6p25.3 was a susceptibility SNP for never smokers [combined odds ratio (OR) = 1.34, 95% confidence interval (CI) = 1.20-1.50, P value = 5.18 x 10(-7)]; and rs12216499 (RSPH3-TAGAP-EZR) on 6q25.3 was a susceptibility SNP for ever smokers (combined OR = 0.75, 95% CI = 0.67-0.84, P value = 6.35 x 10-7). In our analysis of smoking and bladder cancer, the tests for multiplicative interaction seemed to more commonly identify susceptibility loci with associations in never smokers, whereas the additive interaction analysis identified more loci with associations among smokers-including the known smoking and NAT2 acetylation interaction. Our findings provide additional evidence of gene-environment interactions for tobacco and bladder cancer.</p>
  • Figueroa, Jonine D., et al. (författare)
  • Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry
  • 2016
  • Ingår i: Human Molecular Genetics. - Oxford University Press. - 0964-6906 .- 1460-2083. ; 25:6, s. 1203-1214
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Candidate gene and genome-wide association studies (GWAS) have identified 15 independent genomic regions associated with bladder cancer risk. In search for additional susceptibility variants, we followed up on four promising single-nucleotide polymorphisms (SNPs) that had not achieved genome-wide significance in 6911 cases and 11 814 controls (rs6104690, rs4510656, rs5003154 and rs4907479, P &lt; 1 × 10−6), using additional data from existing GWAS datasets and targeted genotyping for studies that did not have GWAS data. In a combined analysis, which included data on up to 15 058 cases and 286 270 controls, two SNPs achieved genome-wide statistical significance: rs6104690 in a gene desert at 20p12.2 (P = 2.19 × 10−11) and rs4907479 within the MCF2L gene at 13q34 (P = 3.3 × 10−10). Imputation and fine-mapping analyses were performed in these two regions for a subset of 5551 bladder cancer cases and 10 242 controls. Analyses at the 13q34 region suggest a single signal marked by rs4907479. In contrast, we detected two signals in the 20p12.2 region—the first signal is marked by rs6104690, and the second signal is marked by two moderately correlated SNPs (r2 = 0.53), rs6108803 and the previously reported rs62185668. The second 20p12.2 signal is more strongly associated with the risk of muscle-invasive (T2-T4 stage) compared with non-muscle-invasive (Ta, T1 stage) bladder cancer (case–case P ≤ 0.02 for both rs62185668 and rs6108803). Functional analyses are needed to explore the biological mechanisms underlying these novel genetic associations with risk for bladder cancer.</p>
  • Fu, Yi-Ping, et al. (författare)
  • The 19q12 Bladder Cancer GWAS Signal : Association with Cyclin E Function and Aggressive Disease
  • 2014
  • Ingår i: Cancer Research. - 0008-5472 .- 1538-7445. ; 74:20, s. 5808-5818
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>A genome-wide association study (GWAS) of bladder cancer identified a genetic marker rs8102137 within the 19q12 region as a novel susceptibility variant. This marker is located upstream of the CCNE1 gene, which encodes cyclin E, a cell-cycle protein. We performed genetic fine-mapping analysis of the CCNE1 region using data from two bladder cancer GWAS (5,942 cases and 10,857 controls). We found that the original GWAS marker rs8102137 represents a group of 47 linked SNPs (with r(2) &gt;= 0.7) associated with increased bladder cancer risk. From this group, we selected a functional promoter variant rs7257330, which showed strong allele-specific binding of nuclear proteins in several cell lines. In both GWASs, rs7257330 was associated only with aggressive bladder cancer, with a combined per-allele OR = 1.18 [95% confidence interval (CI), 1.09-1.27, P = 4.67 x 10(-5)] versus OR = 1.01 (95% CI, 0.93-1.10, P = 0.79) for nonaggressive disease, with P = 0.0015 for case-only analysis. Cyclin E protein expression analyzed in 265 bladder tumors was increased in aggressive tumors (P = 0.013) and, independently, with each rs7257330-A risk allele (P-trend = 0.024). Overexpression of recombinant cyclin E in cell lines caused significant acceleration of cell cycle. In conclusion, we defined the 19q12 signal as the first GWAS signal specific for aggressive bladder cancer. Molecular mechanisms of this genetic association may be related to cyclin E overexpression and alteration of cell cycle in carriers of CCNE1 risk variants. In combination with established bladder cancer risk factors and other somatic and germline genetic markers, the CCNE1 variants could be useful for inclusion into bladder cancer risk prediction models.</p>
  • Lebeaux, Rebecca M, et al. (författare)
  • Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera : The HOME Study.
  • 2020
  • Ingår i: Environmental Research. - 0013-9351 .- 1096-0953. ; 185
  • Tidskriftsartikel (refereegranskat)abstract
    • <p><strong>BACKGROUND:</strong> Per- and polyfluoroalkyl substances (PFAS) are ubiquitous. Previous studies have found associations between PFAS and thyroid hormones in maternal and cord sera, but the results are inconsistent. To further address this research question, we used mixture modeling to assess the associations with individual PFAS, interactions among PFAS chemicals, and the overall mixture.</p><p><strong>METHODS:</strong> We collected data through the Health Outcomes and Measures of the Environment (HOME) Study, a prospective cohort study that between 2003 and 2006 enrolled 468 pregnant women and their children in the greater Cincinnati, Ohio region. We assessed the associations of maternal serum PFAS concentrations measured during pregnancy with maternal (n = 185) and cord (n = 256) sera thyroid stimulating hormone (TSH), total thyroxine (TT<sub>4</sub>), total triiodothyronine (TT<sub>3</sub>), free thyroxine (FT<sub>4</sub>), and free triiodothyronine (FT<sub>3</sub>) using two mixture modeling approaches (Bayesian kernel machine regression (BKMR) and quantile g-computation) and multivariable linear regression. Additional models considered thyroid autoantibodies, other non-PFAS chemicals, and iodine deficiency as potential confounders or effect measure modifiers.</p><p><strong>RESULTS:</strong> PFAS, considered individually or as mixtures, were generally not associated with any thyroid hormones. A doubling of perfluorooctanesulfonic acid (PFOS) had a positive association with cord serum TSH in BKMR models but the 95% Credible Interval included the null (β = 0.09; 95% CrI: -0.08, 0.27). Using BKMR and multivariable models, we found that among children born to mothers with higher thyroid peroxidase antibody (TPOAb), perfluorooctanoic acid (PFOA), PFOS, and perfluorohexanesulfonic acid (PFHxS) were associated with decreased cord FT<sub>4</sub> suggesting modification by maternal TPOAb status.</p><p><strong>CONCLUSIONS:</strong> These findings suggest that maternal serum PFAS concentrations measured in the second trimester of pregnancy are not strongly associated with thyroid hormones in maternal and cord sera. Further analyses using robust mixture models in other cohorts are required to corroborate these findings.</p>
  • van Osch, Frits H M, et al. (författare)
  • Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer: A Pooled Analysis of 15 Case-Control Studies.
  • 2019
  • Ingår i: Epidemiology (Cambridge, Mass.). - 1531-5487. ; 30:3, s. 458-465
  • Tidskriftsartikel (refereegranskat)abstract
    • Few studies have modeled smoking histories by combining smoking intensity and duration to show what profile of smoking behavior is associated with highest risk of bladder cancer. This study aims to provide insight into the association between smoking exposure history and bladder cancer risk by modeling both smoking intensity and duration in a pooled analysis.We used data from 15 case-control studies included in the bladder cancer epidemiology and nutritional determinants study, including a total of 6,874 cases and 17,727 controls. To jointly interpret the effects of intensity and duration of smoking, we modeled excess odds ratios per pack-year by intensity continuously to estimate the risk difference between smokers with long duration/low intensity and short duration/high intensity.The pattern observed from the pooled excess odds ratios model indicated that for a fixed number of pack-years, smoking for a longer duration at lower intensity was more deleterious for bladder cancer risk than smoking more cigarettes/day for a shorter duration. We observed similar patterns within individual study samples.This pooled analysis shows that long duration/low intensity smoking is associated with a greater increase in bladder cancer risk than short duration/high intensity smoking within equal pack-year categories, thus confirming studies in other smoking-related cancers and demonstrating that reducing exposure history to a single metric such as pack-years was too restrictive.
Skapa referenser, mejla, bekava och länka
  • Resultat 11-16 av 16
  • Föregående 1[2]
fritt online (1)
Typ av publikation
tidskriftsartikel (16)
Typ av innehåll
refereegranskat (16)
Karagas, Margaret R. (15)
Vineis, Paolo (11)
Porru, Stefano (11)
Kogevinas, Manolis (10)
Gago Dominguez, Manu ... (9)
Garcia-Closas, Monts ... (9)
visa fler...
Malats, Nuria, (9)
Figueroa, Jonine D (9)
Cortessis, Victoria ... (9)
Carta, Angela (9)
Riboli, Elio (8)
Weiderpass, Elisabet ... (8)
Cancel-Tassin, Geral ... (8)
Bueno-de-Mesquita, H ... (8)
Jacobs, Eric J (8)
Hutchinson, Amy (8)
Cussenot, Olivier (8)
Wang, Zhaoming, (8)
Pike, Malcolm C. (8)
van den Berg, David (8)
De Vivo, Immaculata (8)
Baris, Dalsu (8)
Arici, Cecilia (8)
Chang-Claude, Jenny (7)
Tjonneland, Anne (7)
Krogh, Vittorio (7)
Gapstur, Susan M (7)
Albanes, Demetrius (7)
Trichopoulos, Dimitr ... (7)
Diver, W. Ryan (7)
Ljungberg, Börje, (7)
Black, Amanda (7)
Kooperberg, Charles (7)
Prokunina-Olsson, Lu ... (7)
Yuan, Jian-Min (7)
Rothman, Nathaniel, (7)
Siddiq, Afshan (7)
Tardon, Adonina, (7)
Wu, Xifeng (7)
Lindstrom, Sara (7)
Prescott, Jennifer (7)
Stern, Mariana C (7)
Carrato, Alfredo (7)
Benhamou, Simone (7)
Hohensee, Chancellor (7)
Pavanello, Sofia (7)
Mastrangelo, Giusepp ... (7)
Serra, Consol (7)
Garcia-Closas, Reina (7)
Lloreta, Josep (7)
visa färre...
Umeå universitet (7)
Göteborgs universitet (3)
Lunds universitet (3)
Uppsala universitet (2)
Karolinska Institutet (2)
Örebro universitet (1)
Engelska (16)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (16)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy